You just read:

MabVax Therapeutics Announces Completion of Enrollment and Dosing in Initial Cohort of MVT-1075 Radioimmunotherapy Phase 1 Trial for the Treatment of Pancreatic, Colon and Lung Cancers

News provided by

MabVax Therapeutics Holdings, Inc.

Dec 13, 2017, 06:30 ET